Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort.
about
Assessing risk factors for early hip osteoarthritis in activity-related hip pain: a Delphi studyPrognostic biomarkers in osteoarthritisBiochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled studyIncreased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritisDoes intra-articular fracture change the lubricant content of synovial fluid?Analysis on the serum levels of the biomarker CTX-II in professional indoor soccer players over the course of one seasonMitochondrial haplogroups define two phenotypes of osteoarthritis.The role of synovitis in osteoarthritis pathogenesisPredictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium.Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations.Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study.Racial differences in associations between baseline patterns of radiographic osteoarthritis and multiple definitions of progression of hip osteoarthritis: the Johnston County Osteoarthritis ProjectFragmentation of decorin, biglycan, lumican and keratocan is elevated in degenerate human meniscus, knee and hip articular cartilages compared with age-matched macroscopically normal and control tissuesBiomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the "Magenta osteoarthritis study".Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women.Application of biochemical markers in development of drugs for treatment of osteoarthritis.Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis.Investigational drugs for the treatment of osteoarthritis.Synovium and cartilage biomarkers in hemophilic arthropathy.Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee.The Effects of Morus alba and Acacia catechu on Quality of Life and Overall Function in Adults with Osteoarthritis of the KneeActive involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.Scientific Opinion on the substantiation of a health claim related to glucosamine and maintenance of normal joint cartilage pursuant to Article 13(5) of Regulation (EC) No 1924/2006The value of high-sensitivity C-reactive protein in hand and knee radiographic osteoarthritis: data from the Dong-gu Study.
P2860
Q26784420-20A475B9-7399-48E9-AECE-E5C9EA10EF71Q27022211-CA482864-EFD8-468D-B706-EE35734B9731Q27687777-0FE02BB6-911C-4290-AA24-12B1147A4C0EQ34001775-A37D518B-6215-4FF8-9140-3CAC6BDCFE3EQ35638463-DC816ADA-EFBF-4024-B393-C0CF997CFCAAQ35736650-DC489BB8-1BED-450A-9702-C72739A94A40Q35901585-4776358F-4653-4248-A58F-2B4710B92F70Q35952222-55FA887C-33FC-4DEE-ACDD-494896B98009Q36024641-9D0F8AE0-6322-4AB1-8ED6-887DCA769878Q36050803-C8CB51B7-C2E3-4777-98E9-285CA3472A74Q36059429-9C6C3BF8-6004-4B38-B424-7AF5C0CE31ACQ36230822-F38A8917-95CD-4C55-8498-58C59E76A7ECQ36440009-6B6A94AE-6C1D-41B0-83FF-50CAB56F804DQ36955365-3AA76A7F-C179-477F-8641-6E452C1A9628Q37131543-9B8FDD13-C240-4D85-93A2-8796790E2FFFQ37457066-430D021D-1804-4D9B-80E9-499BECC0AD0DQ37677789-E07A0981-40D5-4A5A-831D-D7B8DF7A43B7Q38173342-B9EC1464-A275-4B29-845E-9397683E0040Q38597565-A711D1AD-6FC4-4DFD-BC5C-9FD22B589551Q38694802-282757FE-06F3-45CA-B583-06D6FB55172EQ38800946-C28A43A2-DC2F-4539-86F3-B63128E1772CQ41785351-8AA489F2-DE04-4AE9-923E-44953ED512ACQ42728527-651E3D58-382E-4CB7-850C-1AB230CE9881Q43905357-9586425B-B8F1-4A9E-AEC7-6B186FA6C62EQ47151673-6BA66FA1-0D1F-42DC-A43B-155E1DD0FD74Q47375256-0F93C6A2-EBF0-456F-9135-4835C190DF16
P2860
Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular markers of cartilage ...... rthritis. The ECHODIAH Cohort.
@ast
Molecular markers of cartilage ...... rthritis. The ECHODIAH Cohort.
@en
type
label
Molecular markers of cartilage ...... rthritis. The ECHODIAH Cohort.
@ast
Molecular markers of cartilage ...... rthritis. The ECHODIAH Cohort.
@en
prefLabel
Molecular markers of cartilage ...... rthritis. The ECHODIAH Cohort.
@ast
Molecular markers of cartilage ...... rthritis. The ECHODIAH Cohort.
@en
P2093
P2860
P356
P1476
Molecular markers of cartilage ...... rthritis. The ECHODIAH Cohort.
@en
P2093
B Mazières
J-P Salles
M Dougados
M Lequesne
P2860
P304
P356
10.1136/ARD.2005.037275
P407
P577
2005-12-01T00:00:00Z